After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, DXCM falls under the Healthcare sector while operating within the Medical Devices industry segment. The current market capitalization of Dexcom Inc is $53.15B. A total of 3.24 million shares were traded on the day, compared to an average of 3.04M shares.
In the most recent transaction, Dolan Matthew Vincent sold 1,990 shares of DXCM for 137.81 per share on Apr 15 ’24. After the transaction, the EVP Strategy and Corporate Dev now owns 42,377 company shares. In a previous transaction on Apr 08 ’24, SAYER KEVIN R sold 49,633 shares at 138.30 per share. DXCM shares that President CEO and Chairman owns now total 283,893.
Among the insiders who sold shares, Brown Michael Jon disposed of 2,624 shares on Mar 28 ’24 at a per-share price of $140.04. This resulted in the EVP Chief Legal Officer holding 68,682 shares of DXCM after the transaction. In another insider transaction, Stern Sadie sold 4,137 shares at $140.00 per share on Mar 25 ’24. Company shares held by the EVP Chief Human Resources now total 76,304.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, DXCM has a high of $142.00 and a low of $74.75.
As of this writing, DXCM has an earnings estimate of $0.27 per share for the current quarter. EPS was calculated based on a consensus of 20.0 estimates, with a high estimate of $0.34 per share and a lower estimate of $0.21. The company reported an EPS of $0.17 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. DXCM’s latest balance sheet shows that the firm has $2.73B in Cash & Short Term Investments as of fiscal 2021. There were $2.16B in debt and $720.80M in liabilities at the time. Its Book Value Per Share was $5.37, while its Total Shareholder’s Equity was $2.04B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DXCM is Buy with a score of 4.76.
